doi:10.1371/journal.pgen.1002325
PMID: Summary Keywords autoimmune diseases, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, incretin-based therapy, psoriasis, real-world evidence Citation Chiang Y-L, Li T-H, Fang Y-W, Liu Y-F, Wu J and Tsai M-H (2026) Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation
Acute Medical Complications The most significant risk of overstimulating the pancreas with multiple agonists is acute pancreatitis
Yes, both nicotine and Mounjaro can contribute to dehydration, especially if side effects like nausea or vomiting occur
Interestingly, adjusting for the decrease in HbA1C in the treatment group attenuated the renal effects of dulaglutide by about 26%, suggesting that the efficacy of GLP1RA is independent of their ability to alter this major CKD risk factor [71]